Results 91 to 100 of about 8,535 (171)

Case of Extensively Drug-Resistant Shigella sonnei Infection, United States. [PDF]

open access: yesEmerg Infect Dis, 2023
Choi H   +6 more
europepmc   +1 more source

Enhanced virulence and stress tolerance are signatures of epidemiologically successful Shigella sonnei. [PDF]

open access: yesNat Commun
Miles SL   +16 more
europepmc   +1 more source

Escherichia coli killing by epidemiologically successful sublineages of Shigella sonnei is mediated by colicins. [PDF]

open access: yesEBioMedicine, 2023
De Silva PM   +10 more
europepmc   +1 more source

<i>Shigella sonnei</i> and <i>Shigella flexneri</i>: Epidemiology supporting development of cross-protective vaccines. [PDF]

open access: yesHum Vaccin Immunother
Caradonna V   +6 more
europepmc   +1 more source

The evolution and international spread of extensively drug resistant Shigella sonnei. [PDF]

open access: yesNat Commun, 2023
Mason LCE   +22 more
europepmc   +1 more source

Epidemiologic and Genomic Investigation of Sexually Transmitted Shigella sonnei, England. [PDF]

open access: yesEmerg Infect Dis
Charles H   +8 more
europepmc   +1 more source

Rapid emergence of extensively drug-resistant Shigella sonnei in France. [PDF]

open access: yesNat Commun, 2023
Lefèvre S   +11 more
europepmc   +1 more source

Therapeutic potential of Shigella phage SSG23 against Shigella sonnei biofilms and in BALB/c mice. [PDF]

open access: yesNpj Viruses
Mondal P   +6 more
europepmc   +1 more source

Genomic Modeling of an Outbreak of Multidrug-Resistant Shigella sonnei, California, USA, 2023-2024. [PDF]

open access: yesEmerg Infect Dis
Lloyd T   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy